The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility
Open accessAbstract
Group B streptococci (GBS; Streptococcus agalactiae ) are the leading cause of neonatal invasive diseases and are also important pathogens for adults. Penicillins are the drugs of first choice for the treatment of GBS infections, since GBS have been regarded to be uniformly susceptible to penicillins so far. Here we characterize the first strains of GBS with reduced penicillin susceptibility (PRGBS) identified in Japan. Fourteen PRGBS strains were clinically isolated from the sputa of elderly patients from 1995 to 2005; and the MICs of penicillin, oxacillin, and ceftizoxime ranged from 0.25 to 1 μg/ml, 2 to 8 μg/ml, and 4 to 128 μg/ml, respectively. Moreover, some strains were also insusceptible to ampicillin, cefazolin, cefepime, and cefotaxime. All the PRGBS isolates tested possessed a few amino acid substitutions adjacent to the conserved SSN and KSG motifs (amino acids 402 to 404 and 552 to 554, respectively) of PBP 2X, and the amino acid substitutions could be classified into two types, Q557E and V405A. Western blotting analysis of the 14 clinical isolates with anti-PBP 2X-specific serum suggested that the amount of PBP 2X among the 14 PRGBS isolates was reduced, although the 2 ATCC strains produced a significant amount of PBP 2X. The introduction of PRGBS-derived PBP 2X genes into penicillin-susceptible strains through allelic exchange elevated their penicillin insusceptibility, suggesting that these altered PBP 2X genes are responsible for the penicillin insusceptibility in PRGBS strains. In this study, we characterized for the first time PRGBS strains on a molecular basis, although several reports have so far mentioned the existence of β-lactam-insusceptible GBS from a phenotypic standpoint.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., Hadler, J. L., Danila, R., Cieslak, P. R., & Schuchat, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420103 · Cited by 1,024
Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
Stoll, B. J., Hansen, N., Fanaroff, A. A., Wright, L. L., Carlo, W. A., Ehrenkranz, R. A., Lemons, J. A., Donovan, E. F., Stark, A. R., Tyson, J. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012657 · Cited by 810
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Schuchat, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.497 · Cited by 609
Prevention of Perinatal Group B Streptococcal Disease: (548432006-001)
(2002) · PsycEXTRA Dataset · doi:10.1037/e548432006-001 · Cited by 554
A Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults
Farley, M. M., Harvey, C., Stull, T., Smith, J. D., Schuchat, A., Wenger, J. D., & Stephens, D. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282503 · Cited by 496
Group B Streptococcal Disease in Nonpregnant Adults
Farley, M. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322696 · Cited by 451
High-efficiency gene inactivation and replacement system for gram-positive bacteria
Biswas, I., Gruss, A., Ehrlich, S. D., & Maguin, E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.11.3628-3635.1993 · Cited by 443
Group B Streptococcal Infections
Baker, C. J. (1997) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30184-2 · Cited by 433
Schuchat, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07128-1 · Cited by 386
Group B Streptococcal Infections in Elderly Adults
High, K. P., Edwards, M. S., & Baker, C. J. (2005) · Clinical Infectious Diseases · doi:10.1086/432804 · Cited by 383
Group B Streptococcus: global incidence and vaccine development
Johri, A. K., Paoletti, L. C., Glaser, P., Dua, M., Sharma, P. K., Grandi, G., & Rappuoli, R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1552 · Cited by 333
Revised Guidelines for Prevention of Early-onset Group B Streptococcal (GBS) Infection
Committee on Infectious Diseases and Committee on Fetus and Newborn (1997) · Pediatrics · doi:10.1542/peds.99.3.489 · Cited by 313
Group B streptococcal disease in UK and Irish infants younger than 90 days
Heath, P. T., Balfour, G., Weisner, A. M., Efstratiou, A., Lamagni, T. L., Tighe, H., O'Connell, L. A., Cafferkey, M., Verlander, N. Q., Nicoll, A., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15389-5 · Cited by 269
Risk Factors for Group B Streptococcal Disease in Adults
Jackson, L. A., Hilsdon, R., Farley, M. M., Harrison, L. H., Reingold, A. L., Plikaytis, B. D., Wenger, J. D., & Schuchat, A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-6-199509150-00003 · Cited by 263
Lu, J., Perng, C., Lee, S.-Y., & Wan, C.-C. (2000) · Journal of Clinical Microbiology · doi:10.1128/.38.6.2076-2080.2000 · Cited by 260
Hansen, S. M., Uldbjerg, N., Kilian, M., & Sørensen, U. B. S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.83-89.2004 · Cited by 245
Group B Streptococcal Infections in Neonates
Baker, C. J. (1979) · Pediatrics in Review · doi:10.1542/pir.1-1-5 · Cited by 226
Prevention of early-onset group B streptococcal disease in newborns
Pearlman, M. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00583-0 · Cited by 196
Group B streptococcal infections
Fernández, M., & Baker, C. J. (1999) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(99)80041-7 · Cited by 155
Framson, P. E., Nittayajarn, A., Merry, J., Youngman, P. J., & Rubens, C. E. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.9.3539-3547.1997 · Cited by 113
Cited by
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03703.x · Cited by 683
Acute bacterial meningitis in infants and children
Kim, K. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70306-8 · Cited by 454
Schrag, S. J., & Verani, J. R. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.11.056 · Cited by 306
Megli, C. J., Carlin, S. M., Giacobe, E. J., Hillebrand, G. H., & Hooven, T. A. (2025) · Virulence · doi:10.1080/21505594.2025.2451173 · Cited by 24
“While there have been a few reports of borderline GBS sensitivity to β-lactam antibiotics [30,31], there has never been documented emergence of high-level resistance.”
Metadata
- Authors
- Kimura, K., Suzuki, S., Wachino, J.-I., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Kato, H., Shibayama, K., & Arakawa, Y.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-08
- Volume
- 52
- Issue
- 8
- Pages
- 2890-2897
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2149467373
- Cited by
- 306
- References
- 20
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.